Please use this identifier to cite or link to this item:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/69085
Full metadata record
???org.dspace.app.webui.jsptag.ItemTag.dcfield??? | Value | Language |
---|---|---|
dc.contributor.advisor | 李伯訓(Bor-Shiunn Lee) | |
dc.contributor.author | Jheng-Yang Wang | en |
dc.contributor.author | 王政揚 | zh_TW |
dc.date.accessioned | 2021-06-17T02:51:08Z | - |
dc.date.available | 2020-09-13 | |
dc.date.copyright | 2017-09-13 | |
dc.date.issued | 2017 | |
dc.date.submitted | 2017-08-15 | |
dc.identifier.citation | 1. Giannoudis PV, Dinopoulos H, and Tsiridis E. Bone substitutes: an update. Injury, 2005. 36(3 Supplement): p. S20-S27. 2. Zhitomirsky I. Electrophoretic hydroxyapatite coatings and fibers. Materials Letters, 2000. 42(4): p. 262-271. 3. Kim HW, Koh YH, Li LH, Lee S, and Kim HE. Hydroxyapatite coating on titanium substrate with titania buffer layer processed by sol–gel method. Biomaterials, 2004. 25(13): p. 2533-2538. 4. Chang E, Chang WJ, Wang BC, and Yang CY. Plasma spraying of zirconia-reinforced hydroxyapatite composite coatings on titanium: part I phase, microstructure and bonding strength. Journal of Materials Science: Materials in Medicine, 1997. 8(4): p. 193-200. 5. Kweh SWK, Khor KA, and Cheang P. An in vitro investigation of plasma sprayed hydroxyapatite (HA) coatings produced with flame-spheroidized feedstock. Biomaterials, 2002. 23(3): p. 775-785. 6. Sun L, Berndt CC, Gross K A, and Kucuk A. Material fundamentals and clinical performance of plasma-sprayed hydroxyapatite coatings: a review. Journal of Biomedical Materials Research, 2001. 58(5): p. 570-592. 7. Amin S. A review on thermal spray coating processes. International Journal of Current Trends in Engineering Research, 2016. 2(4): p. 556-563. 8. Saber SS, and Berndt CC. IFTHSE Global 21: heat treatment and surface engineering in the twenty-first century part 10 – thermal spray coatings: a technology review. International Heat Treatment and Surface Engineering, 2013. 4(1): p. 7-13. 9. Hayek E, Newesely H, and Rumpel ML. Pentacalcium monohydroxyorthophosphate. Inorganic Syntheses, 1963. 7: p. 63–65. 10. Hench LL, and Larry L. Bioceramics: from concept to clinic. Journal of the American Ceramic Society, 1991. 74(7): p. 1487-1510. 11. Wang M. Developing bioactive composite materials for tissue replacement. Biomaterials, 2003. 24(13): p. 2133-2151. 12. Shorr E, and Carter AC. The usefulness of strontium as an adjuvant to calcium in the remineralization of the skeleton in man. Bulletin of the Hospital for Joint Diseases, 1952. 13(1): p. 59-66. 13. Canalis E, Hott M, Deloffre P, Tsouderos Y, and Marie PJ. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone, 1996. 18(6): p. 517-523. 14. Buehler J, Chappuis P, Saffar JL, Tsouderos Y, and Vignery A. Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). Bone, 2001. 29(2): p. 176-179. 15. Hott M, Deloffre P, Tsouderos Y, and Marie PJ, S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone, 2003. 33(1): p. 115-123. 16. Marie PJ, Ammann P, Bovin G, and Ray C, Mechanisms of action and therapeutic potential of strontium in bone. Calcified Tissue International, 2001. 69(3): p. 121-129. 17. Marie PJ, Hott M, Modrowski D, De Pollak C, Guillemain J, Deloffre P, and Tsouderos Y, An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. Journal of Bone and Mineral Research, 1993. 8(5): p. 607-615. 18. Grynpas MD, and Marie PJ. Effects of low doses of strontium on bone quality and quantity in rats. Bone 1990. 11(5): p. 313-319. 19. Rude RK, Singer FR, and Gruber HE, Skeletal and hormonal effects of magnesium deficiency. The Journal of the American College of Nutrition, 2009. 28(2): p. 131-141. 20. Schmitt CM, Koepple M, Moest T, Neumann K, Weisel T, and Schlegel K. A. In vivo evaluation of biofunctionalized implant surfaces with a synthetic peptide (P-15) and its impact on osseointegration. A preclinical animal study. Clinical Oral Implants Research, 2016. 27: p. 1339-1348. 21. Kehoe S, Ardhaoui M, and Stokes J. Design of experiments study of hydroxyapatite synthesis for orthopaedic application using fractional factorial design. Journal of Materials Engineering and Performance, 2010. 20(8): p. 1423-1437. 22. Zhang JZ, Tse KF, Wong MH, Zhang YO, and Zhu JY. A brief review of co-doping. Frontiers of Physics, 2016. 11(6): p. (117405-1)-(117405-21). 23. Ein, Cheryl, and Olivia, 生物醫用材料. 股感知識庫, 2015. 24. Ramakrishna S, Ramalingam M, Kumar TSS, and Winston OS. Biomaterials: A nano approach. CRC Press, 2010: p. 1-372. 25. Albee FH. Studies in bone growth: triple calcium phosphate as a stimulus to osteogenesis. Annals of Surgery, 1920. 71(1): p. 32-36. 26. Hench LL, Splinter RJ, Allen WC, and Greenlee TK. Bonding mechanisms at the interface of ceramic prosthetic materials. Journal of Biomedical Materials Research, 1971. 5(6): p. 117-141. 27. Larry L, and Wilson J. An introduction to bioceramics. Advanced Series in Ceramics, 1993. 1: p. 396. 28. Hench LL, and West JK. Biological applications of bioactive glasses. Life Chemistry Reports, 1996. 13: p. 187-241. 29. Kokubo T, Ito S, Shigematsu M, Sakka S, and Yamamuro T. Mechanical properties of a new type of apatite-containing glass-ceramic for prosthetic application. Journal of Materials Science, 1985. 20(6): p. 2001-2004. 30. Kitsugi T, Yamamuro T, and Kokubo T. Bonding behavior of a glass-ceramic containing apatite and wollastonite in segmental replacement of the rabbit tibia under load-bearing conditions. The Journal of Bone and Joint Surgery, 1989. 71: p. 264-272. 31. Ido K, Matsuda Y, Yamamuro T, Okumura H, Oka M, and Takagi H. Cementless total hip replacement. Bio-active glass ceramic coating studied in dogs. Acta Orthopaedica Scandinavica, 1993. 64(6): p. 607-612. 32. Lin FH, Lin CC, Lu CM, Liu HC, Sun JS, and Wang CY. Mechanical properties and histological evaluation of sintered β-Ca2P2O7 with Na4P2O7 • 10H2O addition. Biomaterials, 1995. 16(10): p. 793-802. 33. Hench LL, and Ethridge EC. Biomaterials: an interfacial approach. Academic Press, 1982. 34. Lemons JE. Ceramics: past, present, and future. Bone, 1996. 19(1 Suppl): p. 121S-128S. 35. Boyde A, and Shapiro IM. Morphological observations concerning the pattern of mineralization of the normal and the rachitic chick growth cartilage. Anatomy and Embryology, 1987. 175(4): p. 457-66. 36. Matsukawa S, Hayakawa T, and Nemoto K. Development of high-toughness resin for dental applications. Dental Materials Journal 1994 10(6): p. 343-346. 37. Koegler WS, and Griffith LG. Osteoblast response to PLGA tissue engineering scaffolds with PEO modified surface chemistries and demonstration of patterned cell response. Biomaterials, 2004. 25: p. 2819-2830. 38. Cook SD, Kay JF, Thomas KA, and Jarcho M. Interface mechanics and histology of titanium and hydroxylapatite-coated titanium for dental implant applications. The International Journal of Oral Maxillofacial Implants, 1987. 2(1): p. 15-22. 39. Krauser JT, Boner C, and Boner N. Hydroxyapatite coated dental implants. Biological criteria and prosthetic possibilities. Cah Prothese, 1990. 71:p. 56-75. 40. Chino T, Gotoh K, and Veda A. Clinical applications of a hydroxyapatite-coated dental implant. Journal of Oral Implantology, 1991. 8(1): p. 71-74. 41. Paulina S, René B, Marcin G, Andrzej Z, and Dieter S. Electrochemically assisted deposition of hydroxyapatite on Ti6Al4V substrates covered by CVD diamond films — Coating characterization and first cell biological results. Materials Science and Engineering: C, 2016. 59: p. 624-635. 42. Chao S, Jianyong G, Ming W, Jingke F, Dalin W, and Yingchun Z. Ultra-trace silver-doped hydroxyapatite with non-cytotoxicity and effective antibacterial activity. Materials Science and Engineering: C, 2015. 55: p. 497-505. 43. Gross BD, Nevins A, and Laporta R. Bone-induction potential of mineralized collagen gel xenografts. Oral Surgery, Oral Medicine, Oral pathology, Oral Radiology, 1980. 49(1). 44. Mittelmeer H, and Grabowski MT. Healing of bone defects after using the preparation 'collapat'. Chirurgia Narzadow Ruchu I Ortopedia Polska, 1983. 48(5-6): p. 483-488. 45. Buare G. Biochemical aspects osseointegration in CRC handbook of bioactive ceramics. CRC Press, 1990. 1: p. 81-97. 46. Heimke G. The aspects and methods of fixation of bone replacement, in osseo-integrated implant vol. I basics. Materials Joint Replacement, 1990: p. 1-26. 47. de Lange GL, de Putter C, and de Wijs FLJA. Histological and ultrastructural appearance of the hydroxyapatite-bone interface. Journal of Biomedical Materials Research, 1990. 24: p. 829-845 48. Hoogendoorn HA, Renooij W, Akkermans LM, Visser W, and Wittebol P. Long-term study of large ceramic implants (porous hydroxyapatite) in dog femora. Clinical Orthopaedics and Related Research, 1984 187: p. 281-288. 49. van Blitterswijk CA, Hesseling S. C., Grote J. J., Koerten H. K., and de Groot K., The biocompatibility of hydroxyapatite ceramic: a study of retrieved human middle ear implants. Journal of Biomedical Materials Research, 1990. 24(4): p. 433-453. 50. Kotani S, Fujita Y, Kitsugi T, Nakamura T, and Yamamuro T. Bone bonding mechanism of ptricalcium phosphate. Journal of Biomedical Materials Research, 1991. 25: p. 1303-1315. 51. Neo M, Kotani S, Fujita Y, Nakamura T, Yamamuro T, Bando Y, Ohtsuki C, and Kokubo T. Differences in ceramic-bone interface between surface-active ceramics and resorbable ceramics: a study by scanning and transmission electron microscopy. Journal of Biomedical Materials Research, 1992 26(2): p. 255-267. 52. Levin EM, Robbins CR, and McMurdie HF. Phase diagrams for ceramists. Columbus Ohio : American Ceramic Society, 1964. 53. Newesely H, and Osborn JF. Mechanical properties of biomaterials. John Wiley Sons Ltd., 1980. 465. 54. Weng J, Cal T, Chen J, and Zheng X. Significance of water promoting amorphous to crystalline conversion of apatite in plasma sprayed coating. Journal of Materials Science Letters, 1995. 14: p. 211-213. 55. LeGeros RZ. Calcium phosphates in oral biology and medicine. Monographs in Oral Science 1991. 15: p. 1-201. 56. de Groot K., Bioceramics of calcium phosphate. CRC Press, 1983. 57. Hulbert SF, Bokros JC, Hench LL, Wilson W, and Heimke G. Ceramics in clinical applications, past, present and future. Ceramics in Clinical Applicant, 1987: p. 3-27. 58. Bronzino JD. The biomedical engineering handbook. CRC Press, 1995: p. 56. 59. de Groot K. Bioceramics consisting of calcium phosphate salts. Biomaterials, 1980. 1: p. 47-50. 60. Ignjatovie N, Tomic S, Dakic M, Miljkovie M, Plavsic M, and Uskokovic D. Synthesis and properties of hydroxyapatite/poly-L-lactide composite biomaterials. Biomaterials, 1999. 20: p. 809-816. 61. Nie X, Leyland A, and Matthews A. Deposition of layered bioceramic hydroxyapatite/TiO2 coatings on titanium alloys using a hybrid technique of micro-arc oxidation and electrophoresis. Surface and Coatings Technology, 2000. 125 p. 407-414. 62. Driessen FCM. Formation and stability of calcium phosphates in relation to the phase composition of the mineral in calcified tissue in Bioceramic of Calcium Phosphate. CRC Press, 1983: p. 1-32. 63. Li ZY, Lam WM, Yang C, Xu B, Ni GX, Abbah SA, Cheung KM, Luk KD, and Lu WW. Chemical composition, crystal size and lattice structural changes after incorporation of strontium into biomimetic apatite. Biomaterials, 2007. 28(7): p. 1452-1460. 64. Root MJ. Inhibition of the amorphous calcium phosphate transformation reaction by polyphosphonates and metal-ions. Calcified Tissue International 1990. 47(2): p. 112-116. 65. Okamoto Y, and Hidaka S. Studies on calcium-phosphate precipitation: effects of metal-ions used in dental materials. Journal of Biomedical Materials Research, 1994. 28(12): p. 1403-1410. 66. Bigi A, Foresti E, Gandolfi M, Gazzano M, and Rovri N, Inhibiting effect of Zinc on hydroxyapatite crystallization. Journal of Inorganic Biochemistry, 1995. 58(1): p. 49-58. 67. Kanzaki N, Onuma K, Treboux G, Tsutsumi S, and Ito A. Inhibitory effect of magnesium and zinc on crystallization kinetics of hydroxyapatite (0001) face. The Journal of Physical Chemistry B, 2000. 104(17): p. 4189-4194. 68. Ito A, Ojima K, Naito H, Ichinose N, and Tateish T. Preparation, olubility, and cytocompatibility od zinc-releasing calcium phosphate eramics. Journal of Biomedical Materials Research, 2000. 50: p. 178-183. 69. Kawamura H, Ito A, Miyakawa S, Layrolle P, Ojima K, Ichinose N, and Tateishi T. Stimulatory effect of zinc-releasing calcium phosphate mplane on bone formation in rabbit femora. Journal of Biomedical aterials Research, 2000. 50: p. 184-190. 70. Moonga BS, and Dempster DW. Zinc is a potent inhibitor of steocalstic bone resorption in vitro. Journal of Bone and Mineral Research, 1995. 10: p. 453-457. 71. Bernstein LR, Mechanisms of therapeutic activity for gallium. Pharmacological Reviews, 1998. 50: p. 665-682. 72. Melnikov P, Malzac A, and Coelho MB, Gallium and bone patholog. Acta Ortopedica Brasileira, 2008. 16 p. 54-57. 73. Melnikov P, Teixeira AR, Malzac A, and de B. Coelho M. Gallium-containing hydroxyapatite for potential use in orthopedics. Materials Chemistry and Physics, 2009. 117 p. 86-90. 74. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Meunier PJ, Pors-Nielsen S, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, and Reginster JY. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. The New England Journal of Medicine, 2004. 350 p. 459-468. 75. Qiu K, Zhao XJ, Wan CX, Zhao CS, and Chen YW. Effect of strontium ions on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffolds. Biomaterials, 2006. 27: p. 1277-1286. 76. Wu C, Ramaswamy Y, Kwik D, and Zreiqat H. The effect of strontium incorporation into CaSiO3 ceramics on their physical and biological properties. Biomaterials, 2007. 28: p. 3171-3181. 77. Xue W, Hosick HL, Bandyopadhyay A, Bose S, Ding C, Luk KDK., Cheung K MC, and Lu WW. Preparation and cell-materials interactions of plasma sprayed strontium-containing hydroxyapatite coating. Surface Coatings Technology, 2007. 201: p. 4685-4693. 78. Marie PJ, Garba MT, Hott M, and Miravet L. Effect of low doses of stable strontium on bone metabolism in rats. Mineral and Electrolyte Metabolism, 1985. 11: p. 5-13. 79. Marie PJ, and Hott M. Short-term effects of fluoride and strontium on bone formation and resorption in the mouse. Metabolism, 1986. 35: p. 547-551. 80. Grynpas MD, Hamilton E, Cheung R, Tsouderos Y, Deloffre P, Hott M, and Marie PJ. Strontium increases vertebral bone volume in rats at a low dose that does not induce mineralization defect. Bone, 1996. 18: p. 253-259. 81. Farlay D, Boivin G, Panczer G, Lalande A, and Meunier PJ. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone. Journal of Bone and Mineral Research, 2005. 20 p. 1569-1578. 82. Christoffersen J, Christoffersen MR, Kolthoff N, and Bärenholdt O. Effects of strontium ions on growth and dissolution of hydroxyapatite and on bone mineral detection. Bone, 1997. 20: p. 47-54. 83. Martini LA. Magnesium supplementation and bone turnover. Nutrition Reviews , 1999. 57(7): p. 227-229. 84. Vormann J. Magnesium: nutrition and metabolism. Molecular Aspects of Medicine, 2003. 24(1/3): p. 27-37. 85. Cheng PT, Grabher JJ, and LeGeros RZ. Effects of magnesium on calcium phosphate formation. Magnesium, 1988. 7(3): p. 123-132. 86. Bertoni E, Bigi A, Cojazzi G, Gandolfi M, Panzavolta S, and Roveri N, Nanocrystals of magnesium and fluoride substituted hydroxyapatite. Journal of Inorganic Biochemistry, 1988. 72(1-2): p. 29-35. 87. Mayer I, Schlam R, and Featherstone JD, Magnesium-containing carbonate apatites. Journal of Inorganic Biochemistry, 1997. 66(1): p. 1-6. 88. Okazaki M, Takahashi J, and Kimura H, Comparison of crystallographic properties of Mg, Fe, Na, CO3, F and Cl-containing apatites. The Journal of Osaka University Dental School, 1986. 26: p. 79-89. 89. Wetherell JD, and Smales RJ. Partial denture failures: a longterm clinical survey. Journal of Dentistry, 1980. 8: p. 333-340. 90. Hansen J, and Fibaek B. Clinical experience of auto- and allotransplantation of teeth. International Dental Journal, 1972. 22(2): p. 270-285. 91. Albrektsson T, Brånemark PI, Hansson HA, and Lindström J. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthopaedica Scandinavica, 1981. 52(2): p. 155-170. 92. Michael M. Dental implant materials: commercially pure titanium and titanium alloys. Journal of Prosthodontics, 1999. 8(1): p. 40-43. 93. Simon WF, Joris M, Stig SJ, and Jacob PT. Titanium: a review on exposure, release, penetration, allergy, epidemiology, and clinical reactivity. Contact Dermatitis, 2016. 74(6): p. 323-345. 94. Jung HD, Yook SW, Han CM, Jang TS, Kim HE, Koh YH, and Estrin Y. Highly aligned porous Ti scaffold coated with bone morphogenetic protein-loaded silica/chitosan hybrid for enhanced bone regeneration. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2014. 102(5): p. 913-921. 95. Gopi D, Shinyjoy E, and Kavitha L. Influence of ionic substitution in improving the biological property of carbon nanotubes reinforced hydroxyapatite composite coating on titanium for orthopedic applications. Ceramics International, 2015. 41(4): p. 5454-5463. 96. Zhuo C, Hiroshi N, Margaret W, Anders B, Maud B, and Toru O. In vitro corrosion resistance of titanium made using different fabrication methods. Biomaterials, 1999. 20(2): p. 183-190. 97. Hong L, Xu HC, and de Groot K. Tensile strength of the interface between hydroxyapatite and bone. Journal of Biomedical Materials Research, 1992. 26(1): p. 7-18. 98. 楊永欽, 殘留應力對電漿熔射氫氧基磷灰石塗層與鈦鋁釩合金基材間結合強度之影響研究, 材料科學及工程學系碩博士班. 2003, 台南市國立成功大學. 99. Vijay BBP, Vikas C. A review on thermal spray coating. International Journal of Scientific Engineering Research, 2015. 6(5). 100. Sagar A. A review on thermal spray coating processes. International Journal of Current Trends in Engineering Research, 2016. 2(4): p. 556-563. 101. Saber SS, and Berndt CC. IFTHSE Global 21: heat treatment and surface engineering in the twenty-first century Part 10– Thermal spray coatings: a technology review. International Heat Treatment Surface Engineering, 2013. p 7-13. 102. Juraj, Ruzbarsky, Anton and Panda. Thermal spray. Plasma and Thermal Spraying, 2016: p. pp 49-57. 103. Sun JS, Liu HC, Chang WHS, Li J, Lin FH, and Tai HC. Influence of hydroxyapatite particle size on bone cell activities: an in vitro study. Journal of Biomedical Materials Research, 1998. 39: p. 390-397. 104. Kalfas IH. Principles of bone healing. Neurosurg Focus, 2001. 10(4): p. E1. 105. Albrektsson T, and Johansson C. Osteoinduction, osteoconduction and osseointegration. European Spine Journal, 2001. 10(Suppl 2): p. S96-101. 106. Ramp LC, and Jeffcoat R. Dynamic behavior of implants as a measure of osseointegration. The International Journal of Oral Maxillofacial Implants, 2001. 16(5): p. 637-645. 107. Koch FP, Weng D, Krämer S, Biesterfeld S, Jahn-Eimermacher A, and Wagner W. Osseointegration of one-piece zirconia implants compared with a titanium implant of identical design: a histomorphometric study in the dog. Clinical Oral Implants Research, 2010. 21(3): p. 350-356. 108. Aparicio C, Lang NP, and Rangert B. Validity and clinical significance of biomechanical testing of implant/bone interface Clinical Oral Implants Research, 2006. 17(Suppl 2): p. 2-7. 109. Jande SS. and Bélanger LF. Life cycle of the osteocyte. Clinical Orthopaedics and Related Research, 1973. 94: p. 281. 110. Wang D, Wang H, Gao F, Wang K, and Dong F. ClC-3 promotes osteogenic differentiation in MC3T3-E1 cell after dynamic compression. Journal of Cellular Biochemistry, 2017. 118(6): p. 1606-1613. 111. Jeon EJ, Lee KY, Choi NS, Lee MH, Kim HN, Jin YH, Ryoo HM, Choi JY, Yoshida M, Nishino N, Oh BC, Lee KS, Lee YH, and Bae SC. Bone morphogenetic protein-2 stimulates runx2 acetylation. Journal of Biological Chemistr, 2006. 281: p. 16502-16511. 112. Chatterjee K, Lin-Gibson S, Wallace WE, Parekh SH, Lee YJ, Cicerone MT, Young MF, and Simon CGJR. The effect of 3D hydrogel scaffold modulus on osteoblast differentiation and mineralization revealed by combinatorial screening. Biomaterials 2010. 31: p. 5051-5062. 113. Rath B, Nam J, Knobloch TJ, Lannutti JJ, and Agarwal S. Compressive forces induce osteogenic gene expression in calvarial osteoblasts. Journal of Biomechanics, 2008. 41: p. 1095-1103. 114. Bharadwaj S, Naidu AG, Betageri GV, Prasadarao NV, and Naidu AS. Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women. Osteoporosis International, 2009. 20(9): p. 1603-1611. 115. Dhaliwal JS, Albuquerque RFJR, Murshed M, Feine JS. Osseointegration of standard and mini dental implants: a histomorphometric comparison. International Journal of Implant Dentistry, 2017. 3:15. 116. Camargo WA, Takemoto S, Hoekstra JW, Leeuwenburgh SCG, Jansen JA, van den Beucken JJJP, Alghamdi HS. Effect of surface alkali-based treatment of titanium implants on ability to promote in vitro mineralization and in vivo bone formation. Acta Biomaterialia, 2017. 57: p.511-523. 117. Jovanovic SA, Spiekermann H, Richter EJ. Bone regeneration around titanium dental implants in dehisced defect sites: a clinical study. The International Journal of Oral Maxillofacial Implants, 1992. 7(2): p.233-245. 118. Steven M, van Gaalen, Moyo CK, Ruth E, Geuze, Joost D, de Bruijn, Jacqueline A, and Wouter JAD. Use of fluorochrome labels in in vivo bone tissue engineering research. Tissue Engineering: Part B, 2010. 16(2): p209-217. 119. An YH, and Martin KL. Handbook of histology methods for bone and cartilage, 2003. 120. Mercuri LG, Urban RM, Hall DJ, Mathew MT. Adverse local tissue responses to failed temporomandibular joint implants. Journal of Oral and Maxillofacial Surgery, 2017. 17: p30362-30372. 121. Alexander B, and Maurice YM. In vivo biofunctionalization of titanium patient-specific implants with nano hydroxyapatite and other nano calcium phosphate coatings: a systematic review. Journal of Cranio-Maxillo-Facial Surgery, 2016. 44: p.400-412. 122. Zhen G, Zhenduo C, Zhaoyang L, Shengli Z, Yanqin L, William WL, and Xianjin Y. Synthesis, characterization and the formation mechanism of magnesium- and strontium-substituted hydroxyapatite. Journal Of Materials Chemistry B, 2015. 3: p. 3738-3746. 123. Radin SR, and Ducheyne P. Plasma spraying induced changes of calcium phosphate ceramic characteristics and the effect onin vitro stability. Journal of Materials Science: Materials in Medicine, 1992. 3(1): p. 33-42. 124. Liga S., Kristine SA, Natalija B, Marina S, Dmitrijs J, and Liga BC. Characterization of Mg-substituted hydroxyapatite synthesized by wet chemical method. Ceramics International, 2014. 40(2): p. 3261-3267. 125. Fan Y, Sun Z, and Moradian-Oldak J. Controlled remineralization of enamel in the presence of amelogenin and fluoride. Biomaterials, 2009. 30(4): p. 478-483. 126. Zhang Y, Liu W, Banks CE, Liu F, Li M, Xia F, and Yang X. A fluorescence-quenching platform based on biomineralized hydroxyapatite from natural seashell and applied to cancer cell detection. Scientific Reports, 2014. 4: p. 7556. 127. de Lima IR, Alves GG, Soriano CA, Campaneli AP, Gasparoto TH, Ramos ESJR, de Sena LA, Rossi AM, and Granjeiro JM. Understanding the impact of divalent cation substitution on hydroxyapatite: an in vitro multiparametric study on biocompatibility. Journal of Biomedical Materials Research Part A, 2011. 98(3): p. 351-358. 128. Kaygili O, and Keser S. Zr/Mg, Zr/Sr and Zr/Zn co-doped hydroxyapatites: Synthesis and characterization. Ceramics International, 2016. 42(7): p. 9270-9273. 129. Roy M, Bandyopadhyay A, and Bose S. Induction plasma sprayed Sr and Mg doped nano hydroxyapatite coatings on Ti for bone implant. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2011. 99(2): p. 258-265. 130. Fowler BO, Moreno EC, and Brown WE. Infra-red spectra of hydroxyapatite octacalcium phosphate and pyrolysed octacalcium phosphate. Archives of Oral Biology, 1966. 11(5): p. 477- . 131. Arends J, Christoffersen J, Christoffersen MR, Eckert H, Fowler BO, Heughebaert JC, Nancollas GH, Yesinowski JP, and Zawacki SJ. A calcium hydroxyapatite precipitated from an aqueous-solution - an international multimethod analysis. Journal of Crystal Growth, 1987. 84(3): p. 515-532. 132. O'Donnell MD, Fredholm Y, de Rouffignac A, and Hill RG., Structural analysis of a series of strontium-substituted apatites. Acta Biomaterialia, 2008. 4(5): p. 1455-1464. 133. Boyd AR, utledge LR, Randolph LD., and Meenan B. J. Strontium-substituted hydroxyapatite coatings deposited via co-deposition sputter technique. Materials Science and Engineering C, 2015. 46: p. 290-300. 134. Chung CJ, and Long HY. Systematic strontium substitution in hydroxyapatite coatings on titanium via micro-arc treatment and their osteoblast/osteoclast responses. Acta Biomaterialia, 2011. 7(11): p. 4081-4087. 135. Xue W, Hosick HL, Bandyopadhyay A, Bose S, Ding C, Luk KDK, Cheung KM C, and Lu WW. Preparation and cell-materials interactions of plasma sprayed strontium-containing hydroxyapatite coating. Surface and Coatings Technology, 2007. 201(8): p. 4685-4693. 136. Xu J, Yang Y, Wan R, Shen Y, and Zhang W. Hydrothermal preparation and characterization of ultralong strontium-substituted hydroxyapatite whiskers using acetamide as homogeneous precipitation reagent. Scientific World Journal, 2014. 2014: p. 863137. 137. Serre CM, Papillard M, Chavassieux P, Voegel JC, and Boivin G. Influence of magnesium substitution on a collagen-apatite biomaterial on the production of a calcifying matrix by human osteoblasts. Journal of Biomedical Materials Research, 1998. 42(4): p. 626-633. 138. Diallo GS, Laurencin D, Jean MK, Casale S, Smith ME, Lauron Pernot H., and Costentin G. Influence of magnesium substitution on the basic properties of hydroxyapatites. The Journal of Physical Chemistry C, 2011. 115(49): p. 24317-24327. 139. Park KD, Jung YS, Lee KK, and Park HJ. Behavior of osteoblast-like cells on a beta-tricalcium phosphate synthetic scaffold coated with calcium phosphate and magnesium. Journal of Craniofacial Surgery, 2016. 27(4): p. 898-903. 140. Selvamurugan N, Chou WY, Pearman AT, Pulumati MR, and Partridge NC, Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence. The Journal of Biological Chemistry, 1998. 273: p. 10647-10657. 141. Ducy P, Zhang R, Geoffroy V, Ridall AL, and Karsenty G. Osf2/cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: p. 747-754. 142. Kern B, Shen J, Starbuck M, and Karsenty G, Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. The Journal of Biological Chemistry, 2001. 276(10): p. 7101-7. 143. Xiao G, Wang D, Benson MD, Karsenty G, and Franceschi RT, Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. The Journal of Biological Chemistry, 1998. 273: p. 32988-32994. 144. Fedorovich NE, Kuipers E, Gawlitta D, Dhert WJ, and Alblas J. Scaffold porosity and oxygenation of printed hydrogel constructs affect functionality of embedded osteogenic progenitors. Tissue Engineering Part A, 2011. 17: p. 2473-2486. 145. Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lips P, Smit JH, and van Staveren WA. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. Journal of Bone and Mineral Research, 2005. 20: p. 921-929. 146. Olive J, and Aparicio C. Periotest method as a measure of osseointegrated oral implant stability. The International Journal of Oral Maxillofacial Implants, 1990. 5(4): p. 390-400. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/69085 | - |
dc.description.abstract | 氫氧基磷灰石在現今被廣泛地使用在骨整合研究,對於人體骨骼的組成元素非常相似。過往研究中已證明鍶與鎂微量元素摻雜混入氫氧基磷灰石中,會促進骨母細胞與骨細胞的貼附與增生。本實驗研究macro等級之多孔性的氫氧基磷灰石結構中,鈣離子位置會被鍶與鎂部分取代,利用化學濕式合成法來合成所需微摻元素之粉末,鍶與鎂以不同莫耳比例(0.5, 1, 5, 10 mol%)摻雜其中(xSr-yMg-HA),接著將粉末進行材料鑑定。 材料鑑定分為以X光繞射圖譜分析(XRD)偵測散射角10~60度中的特徵峰比對JCPDS card;利用傅立葉轉換紅外光譜分析(FTIR)與拉曼光譜分析(Raman)則是鑑定分析主要官能基磷酸根(PO43-)、氫氧基(OH-)是否存在;而使用掃描式電子顯微鏡(SEM)可以觀察粉末顆粒表面的微觀現象,摻雜鍶與鎂之微量元素,其形狀會呈現棒狀與團塊狀的差別;再用X射線光電子能譜分析(XPS)去分析量測元素摻雜比例是否正確和鈣磷比的比例範圍。 運用火焰噴塗薄膜技術,將粉末噴塗覆蓋於細胞所需之純鈦基材與動物實驗所需之牙根表面,來進行生物相容性試驗。實驗細胞株為人類胚胎上顎間質細胞(HEPM cells),利用此細胞來研究本實驗中其合成材料的生物相容性與生物活性。在細胞存活率分析(MTT assay)與鹼性磷酸酶試驗(ALP assay),實驗天數為第3、7、11天,發現在第11天時5Sr-5Mg-HA組(Sr0.5Mg0.5Ca9 (PO4)6(OH)2)的細胞生長與礦化情況最佳,ALP蛋白含量高達65 ng/µl;即時定量聚合酶鏈鎖反應(Real-time PCR)去分析基因的層次,可以發現上游轉錄因子RUNX2與礦化調控基因OPN、OCN,5Sr-5Mg-HA組之DNA產物量在第11天時最為明顯;偵測蛋白質表現含量的西方墨點法(Western blot),5Sr-5Mg-HA組的RUNX2與OPN蛋白質表現,在時間點第11天時表現含量增加;利用人類骨鈣素即時定量ELISA試劑組(Human Osteocalcin Instant ELISA Kit)將OCN蛋白質表現定量,也發現在第11天時與各組比較,具有顯著差異,OCN蛋白質含量約18.5 ng/ml,也印證基因分析表現的一致性。 除了材料鑑定和體外細胞分析測試(in vitro)之外,本實驗也進行了相關動物實驗(in vivo)的研究,各別為市售Ti植體、HA-Ti植體與5Sr-5Mg-HA-Ti植體等三組進行實驗。在植牙實驗的時間點2、4、8週分別皮下注射骨螢光染劑標定,以觀察不同時間點之骨新生,可以發現5Sr-5Mg-HA組在各時間點與他組比較,骨新生情況最佳;而觀察期間之植體動搖度,其測量處為頰舌側與近心遠心側部份,各組都符合臨床上的植體動搖度範圍;在動物犧牲後取得之標本,以X光與micro CT計算骨覆蓋率(BC%)、骨量(BV)、骨密度(BMD)、植體-骨組織接觸面積(BIC);在第8週的骨覆蓋率比較,對照組HA-Ti植體(84.46±5.27%)和實驗組5Sr-5Mg-HA-Ti植體(86.61±3.18%)兩者無顯著差異,但與空白組Ti植體(73.67±3.43%)比較則有顯著差異;而骨量、骨密度、植體-骨組織接觸比率,在時間點2、4、8週觀察,三組皆無顯著差異;再以脫鈣(Hematoxylin-Eosin Staining)、非脫鈣研磨染色(Stevenel’s blue Alizarin red S Staining)與骨螢光染色(Bone Fluorescence Label)實驗觀察組織切片,可以發現5Sr-5Mg-HA組之骨整合最佳。 藉由體外細胞實驗與動物實驗進行全面的生物相容性測試與骨整合分析,準確評估在生物方面的合成材料之優缺點,以準備未來臨床方面之相關研究。 | zh_TW |
dc.description.abstract | Hydroxyapatite (HA) is widely used in osseointegration research because its compositionis similar to with natural bone. Incorporation of strontium (Sr2+) and magnesium (Mg2+) to HA has been demonstrated to enhance pre-osteoblasts and osteoblasts adhesion. Porous macro-granules of HA with Ca2+ partially co-substituted with Sr2+ and Mg2+ indifferent mole percent ratios (xSr-yMg-HA). In this study, we used wet chemical method to synthesize HA powder which included different ratios of Sr2+and Mg2+ (x=0.5, 1, 5, 10). Human embryonic palatal mesenchyme (HEPM) cells were used to study the biocompatibility and biological activity of materials. MTT assay and alkaline phosphatase activity test were performed to examine the cell proliferation and mineralization. The results showed that the best ratio of Sr2+ and Mg2+ co-doped HA were 5Sr-5Mg-HA (Sr0.5Mg0.5Ca9 (PO4)6(OH)2). ALP protein concentration of 65 ng/μl to be detected. The synthesized powders were further characterized using X-ray diffractometer (XRD) at diffraction angles from 10o to 60o. Moreover, Fourier Transform Infrared Spectroscopy (FTIR) and Raman Spectroscopy were used to examine the functional group changes. X-ray photoelectron spectroscopy (XPS) was used to measure Ca2+, Sr2+, Mg2+ contents and Scanning Electron Microscope (SEM) was used to observe the surface morphology. In addition, we used 5Sr-5Mg-HA powder to coat with coating the pure-Ti implant using the flame spraying technology. We tested the expressions of osteogenesis-related genes, including runt-related transcription factor 2 (RUNX2), osteocalcin (OCN) and osteopontin (OPN), using real-time PCR. Several previous studies have reported that RUNX2 was a master transcription factor and OPN and OCN were late osteogenic markers. They were studied for chondrocyte and osteoblast differentiation and bone formation. Furthermore, Western blot was used to examine protein expression levels. RUNX2 and OPN proteins in the 5Sr-5Mg-HA group showed the high expression level at the 11th day. We measured OCN protein was quantified by the Human Osteocalcin Instant ELISA Kit, and 5Sr5Mg-HA-Ti group had a significant difference. OCN protein had 18.5 ng/ml compared with each group at the 11th day. Besides examining material identification and in vitro assay, we also took out other biocompatibility tests, in vivo, to determine the bio-functionality in a more overall way. We conducted on the related animal experiments about osseointegration function. In this study, self-developed implants in which were coating 50-55 μm particles which have HA-Ti or 5Sr5Mg-HA powder for surface treatment were enrolled in experimental group, and commercial dental Ti implants (OsseoSpeedTM) were enrolled in the control group. Implants in each group were according to the different observation intervals (2, 4 and 8weeks) with randomly distribution at bilateral mandible edentulous area in four beagle dogs. Non-invasive evaluation including clinical observation on the implant status and implant stability analyzer, Periotest, it was used for accessment of degree of osteointegration in the observation period. After animal sacrificed and specimens harvested, X-ray and micro CT could use to measure bone coverage (BC%), bone volume (BV), bone mineral density (BMD) and bone-implant contact (BIC). At the 8th week, bone coverage were no significant differences between the HA-Ti implant (84.46 ± 5.27%) and 5Sr-5Mg-HA-Ti implant (86.61 ± 3.18%), but Ti implant (73.67 ± 3.43%) were significant differences in comparison. However, bone mass, bone density, and bone-implant contact at the time point 2, 4, 8 weeks were no significant difference with the three groups. Bone fluorescence labeling technique with dyes injected at 2, 4 and 8 weeks was used to observe new bone formation. Decalcified and non-decalcified staining could observe the direct contact of the bone tissue with the part of the implant area. We confirmed 5Sr-5Mg-HA group to carry out the best bone formation, remodeling and osseointegration. The comprehensive biocompatibility tests and bone osseointegration analyses were performed by in vitro and in vivo experiments to accurately assess the pros and cons of synthetic materials in biomaterials to prepare future clinical studies. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T02:51:08Z (GMT). No. of bitstreams: 1 ntu-106-R03450004-1.pdf: 56667516 bytes, checksum: b478dd155fbb8cbc9c4297b4b4d899a8 (MD5) Previous issue date: 2017 | en |
dc.description.tableofcontents | 口試委員會審定書 # 誌謝 i 中文摘要 iv ABSTRACT vi 目錄 ix 圖目錄 xiii 表目錄 xviii 第一章 緒論 1 1.1 前言 1 1.2 研究動機與目的 2 1.3 論文架構 3 1.4 實驗流程圖 5 第二章 文獻回顧 6 2.1 生醫材料簡介 6 2.2 生醫材料種類 7 2.3 生醫材料與體內生理環境之反應 10 2.4 氫氧基磷灰石與磷酸鹽類簡介 10 2.5 氫氧基磷灰石結構 14 2.6 氫氧基磷灰石性質與應用 15 2.7 氫氧基磷灰石之合成方法 17 2.8 添加微量元素對氫氧基磷灰石的影響 19 2.9 鍶與鎂離子對於骨癒合的生物作用 20 2.10 人工牙根回顧 23 2.11 鈦金屬應用 24 2.12 薄膜噴塗方法 25 2.13 生物相容性與醫療性器材評估 27 2.14 骨移植、骨癒合與骨整合機制介紹 29 2.15 牙齒結構之介紹 31 2.16 硬組織生成簡介 32 2.17 骨礦化調控 34 第三章 實驗材料、方法與儀器 38 3.1實驗材料 38 3.1.1 實驗藥品與材料合成素材部分(1)~(6) 38 3.1.2 商業粉與基材材料部分 42 3.1.3 細胞培養部分 43 3.1.4 實驗用細胞株 44 3.1.5 實驗用動物 44 3.1.6 實驗用牙科植體之種類 45 3.1.7 實驗用牙科植體所需之器械 45 3.1.8 動物實驗藥品、染劑部分 47 3.2 實驗方法 48 3.2.1 材料實驗方法部分 48 3.2.2 細胞實驗方法部分 55 3.2.3 動物實驗方法部分 68 3.3 實驗儀器介紹 75 3.4 統計方法 79 第四章 實驗結果 80 4.1 材料分析 80 4.1.1 火焰噴塗製備樣品 80 4.1.2 X光繞射圖譜(XRD) 81 4.1.3 傅立葉轉換紅外光譜(ATR-FTIR) 86 4.1.4 拉曼光譜實驗(Raman) 90 4.1.5 掃描式電子顯微鏡(SEM) 96 4.1.6 X射線光電子能譜分析儀器(XPS) 99 4.2 細胞實驗(In vitro) 101 4.2.1 細胞存活率分析(MTT Assay) 101 4.2.2 鹼性磷酸酶試驗(ALP Assay) 107 4.2.3 即時定量聚合酶鏈鎖反應分析(Real-time PCR Analysis) 111 4.2.4 西方墨點法(Western Blot) 117 4.2.5 骨鈣素試驗(Osteocalcin Assay) 120 4.3 動物實驗(In vivo) 122 4.3.1 下顎骨拔牙、植牙與樣品採集 122 4.3.2 植體搖動度測試(PTV) 122 4.3.3 醫用放射線影像分析(X光圖與micro CT) 125 4.3.4 植體周圍齒槽骨再生率(BIC%) 130 4.3.5 骨螢光標定(Bone Fluorescence Label) 132 4.3.6 非脫鈣染色(Non-decalcified Stain) 136 4.3.7 脫鈣染色(Decalcified Stain) 140 第五章 討論 144 5.1 X光繞射圖譜(XRD)分析 144 5.2 傅立葉轉換紅外光譜(ATR-FTIR)分析 145 5.3 拉曼光譜(Raman spectra)分析 145 5.4 掃描式電子顯微鏡(SEM)分析 146 5.5 X射線光電子能譜(XPS)分析 146 5.6 細胞存活率分析(MTT assay) 146 5.7 鹼性磷酸酶分析(ALP assay) 147 5.8 即時定量聚合酶鏈鎖反應分析(Real-time PCR analysis) 147 5.9 西方墨點法(Western blot) 148 5.10 骨鈣素試驗 (Osteocalcin Assay) 148 5.11 植體搖動度測試(PTV) 148 5.12 醫用放射線影像分析(X光圖與micro CT) 149 5.13 植體周圍齒槽骨再生率(BIC%) 149 5.14 骨螢光標定(Bone Fluorescence Label) 149 5.15 非脫鈣染色(Non-decalcified Stain) 150 5.16 脫鈣染色(Decalcified Stain) 150 第六章 結論 152 參考文獻 153 | |
dc.language.iso | zh-TW | |
dc.title | 以火焰噴塗氫氧基磷灰石混摻鍶鎂於牙科植體 | zh_TW |
dc.title | Flame Spray Coating of Strontium- and Magnesium-doped Hydroxyapatite on Dental Implant | en |
dc.type | Thesis | |
dc.date.schoolyear | 105-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 童國倫(Kuo-Lun Tung),章浩宏(Hao-Hueng Chang) | |
dc.subject.keyword | 鍶,鎂,氫氧基磷灰石,火焰噴塗技術,牙根植體,骨整合,生物相容性, | zh_TW |
dc.subject.keyword | Strontium,Magnesium,Hydroxyapatite,Flame Spraying Technology,Dental Implant,Osseointegration,Biocompatibility, | en |
dc.relation.page | 166 | |
dc.identifier.doi | 10.6342/NTU201701865 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2017-08-15 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
Appears in Collections: | 口腔生物科學研究所 |
Files in This Item:
File | Size | Format | |
---|---|---|---|
ntu-106-1.pdf Restricted Access | 55.34 MB | Adobe PDF |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.